Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 13]
PHARMAC seeking views on new cystic fibrosis medicine
Friday, 24 January 2020, 1:01 pm | PHARMAC
PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) for people with cystic fibrosis. More >>
PHARMAC considering new medicines for type 2 diabetes
Wednesday, 15 January 2020, 4:44 pm | PHARMAC
PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living with type 2 diabetes. More >>
PHARMAC seeking views on new breast cancer medicine
Wednesday, 15 January 2020, 10:01 am | PHARMAC
PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) for first-line and second-line treatment of certain types of breast cancer. More >>
Spinraza funding application reviewed
Tuesday, 17 December 2019, 9:28 am | PHARMAC
PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for spinal muscular atrophy, is funded in New Zealand. More >>
PHARMAC to fund more cancer medicines and faster assessment
Thursday, 5 December 2019, 9:09 am | PHARMAC
Thousands of New Zealanders with lymphoma, breast, ovarian and blood cancers will have more treatment options available to them in the New Year. More >>
PHARMAC widening access to the meningococcal ACWY vaccine
Thursday, 14 November 2019, 9:38 am | PHARMAC
The meningococcal ACWY vaccine will be available free from next month for young people in close living situations. More >>
PHARMAC funding new leukaemia medicine
Monday, 4 November 2019, 10:19 am | PHARMAC
New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live longer from 1 December 2019. More >>
21,000 to benefit from Mirena and Jaydess
Monday, 14 October 2019, 9:27 am | PHARMAC
PHARMAC is widening funded access to Mirena, as well as listing a new long-acting reversible contraceptive option, Jaydess, which will benefit around 21,000 New Zealand women. More >>
PHARMAC signs bundle deal for more cancer medicines
Monday, 7 October 2019, 1:41 pm | PHARMAC
420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More >>
Lamotrigine brand change from today
Tuesday, 1 October 2019, 12:42 pm | PHARMAC
From today there will be one funded brand of lamotrigine - a medicine used to treat epilepsy and some mental health conditions, including bipolar disorder. More >>
PHARMAC says more medicines on the way
Sunday, 1 September 2019, 3:47 pm | PHARMAC
PHARMAC says more medicines on the way PHARMAC has reached a deal with pharmaceutical companies for three new medicines to treat ovarian cancer, breast cancer and leukaemia. “The $60 million boost means we can make real inroads into funding medicines on ... More >>
Influenza vaccination levels hit near record levels
Thursday, 6 June 2019, 4:04 pm | PHARMAC
Director of Operations of Lisa Williams said this was the highest number of vaccines to have been distributed so early in winter. More >>
1500 New Zealanders access a cure for hepatitis C
Tuesday, 28 May 2019, 11:17 am | PHARMAC
Over 1500 New Zealanders have started a new hepatitis C treatment in the last three months that could dramatically change their lives. More >>
PHARMAC fully funding innovation in haemophilia treatment
Wednesday, 1 May 2019, 1:07 pm | PHARMAC
PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will make a major difference to their lives, PHARMAC Director of Operations Lisa Williams says. More >>
PHARMAC to give more clarity about funding decisions
Tuesday, 30 April 2019, 9:53 am | PHARMAC
An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and are not - being actively considered for funding, Chief Executive, Sarah Fitt says. More >>
PHARMAC funds potential Hepatitis C cure
Monday, 17 December 2018, 1:02 pm | PHARMAC
Life changing treatment for New Zealanders living with hepatitis C will be available from 1 February 2019, after PHARMAC funds a new treatment. The medicine known as Maviret (glecaprevir and pibrentasvir) can be prescribed to people with hepatitis ... More >>
PHARMAC celebrates NZ's Pacific Pharmacists’ Association
Friday, 24 August 2018, 2:15 pm | PHARMAC
PHARMAC is celebrating the formation of New Zealand’s first Pacific Pharmacists’ Association. More >>
Tapuhi Kaitiaki Awards for Māori Nurses launched
Thursday, 28 June 2018, 1:07 pm | PHARMAC
Tapuhi Kaitiaki Awards for Māori Nurses launched PHARMAC and Te Pōari o Te Rūnanga o Aotearoa/Tōpūtanga Tapuhi Kaitiaki o Aotearoa/New Zealand Nursing Organisation (NZNO) are pleased to announce the launch of the Tapuhi Kaitiaki Awards (Māori Nurses ... More >>
Community voices important to PHARMAC
Monday, 28 May 2018, 1:22 pm | PHARMAC
Community voices important to PHARMAC This year, PHARMAC is reviewing the way we seek and incorporate the consumer voice in our work, and is asking people about how we could improve input from, or engagement with, them. PHARMAC Chief Executive, Sarah ... More >>
PHARMAC widening access for Truvada
Wednesday, 7 February 2018, 2:04 pm | PHARMAC
PHARMAC widening access for Truvada for the prevention of HIV infection 7 February 2018 A decision to widen access to Truvada to prevent infection with HIV is a great opportunity to reduce transmission rates of HIV infections in New Zealand, says PHARMAC ... More >>
